Objective: Neuroimaging and other biomarker assays suggest that the pathological processes of Alzheimer's disease (AD) begin years prior to clinical dementia onset. However, some 30 to 50% of older individuals who harbor AD pathology do not become symptomatic in their lifetime. It is hypothesized that such individuals exhibit cognitive resilience that protects against AD dementia. We hypothesized that in cases with AD pathology, structural changes in dendritic spines would distinguish individuals who had or did not have clinical dementia. Methods: We compared dendritic spines within layer II and III pyramidal neuron dendrites in Brodmann area 46 dorsolateral prefrontal cortex using the Golgi-Cox technique in 12 age-matched pathology-free controls, 8 controls with AD pathology (CAD), and 21 AD cases. We used highly optimized methods to trace impregnated dendrites from bright-field microscopy images that enabled accurate 3-dimensional digital reconstruction of dendritic structure for morphologic analyses. Results: Spine density was similar among control and CAD cases but was reduced significantly in AD. Thin and mushroom spines were reduced significantly in AD compared to CAD brains, whereas stubby spine density was decreased significantly in CAD and AD compared to controls. Increased spine extent distinguished CAD cases from controls and AD. Linear regression analysis of all cases indicated that spine density was not associated with neuritic plaque score but did display negative correlation with Braak staging. Interpretation: These observations provide cellular evidence to support the hypothesis that dendritic spine plasticity is a mechanism of cognitive resilience that protects older individuals with AD pathology from developing dementia.
face of aging and disease, a proposed mechanism contributing to cognitive resilience. 8 However, studies providing neurobiological evidence of this in patients with AD pathology are limited. Cognitively normal individuals with AD pathology are proposed to represent individuals who are resilient to dementia or in preclinical stages of AD. 2 This cohort allows exploration of mechanisms that are (1) critical for retaining cognitive function in the face of AD pathology (ie, cognitive resilience) or (2) involved in the transition from preclinical to symptomatic AD. Neuronal synapse loss correlates more strongly with cognitive impairment than classical pathologic markers of AD, 9 ,10 yet whether synapse loss is progressive or synaptic remodeling contributes to cognitive resilience to protect individuals with AD pathophysiology is not known. 11, 12 Excitatory synapses occur on actin-rich dendritic protrusions called dendritic spines, and synapse strength and activity are inseparably linked to spine morphology. 13 We hypothesized that in cases with AD pathology, structural changes in dendritic spines would distinguish individuals who had or did not have clinical dementia. To test this hypothesis, we used highly optimized 3-dimensional modeling of dendritic spines to analyze prefrontal cortex synapse populations from controls, cognitively normal individuals with high AD pathology (CAD), and AD dementia cases.
Subjects and Methods

Human Brain Tissue
Samples of frontal cortex derived from subjects exhibiting a range of AD pathology were examined. Tissue samples were collected at the Emory University Alzheimer's Disease Research Center. The case diagnosis is based on Mini-Mental State Examination (MMSE), Consortium to Establish a Registry for Alzheimer's disease (CERAD) criteria for the neuropathologic diagnosis of AD, and Braak staging of neurofibrillary pathology. Cases were categorized into 3 diagnostic groups, which included (1) 12 cognitively normal controls without AD pathology, (2) 8 cognitively normal control subjects showing moderate to severe AD pathology at autopsy, and (3) 21 definite AD cases with severe pathology. 1,2 The 3 groups were matched as closely as possible for age, sex, and postmortem interval. It is important to note that the majority of these cases had no coexisting pathologies, such as stroke or Lewy body disease. Although multiple neuropsychological tests were employed in the cognitive testing of these subjects, the MMSE is the most commonly used test for complaints of memory problems or when a diagnosis of dementia is being considered, and those results are presented in Table 1 . Severe to moderate AD patients have MMSE scores of 10 to 20 of total possible of 30; at the end stages of disease, impairment is so severe as to prevent testing. Clinical Dementia Rating (CDR) was conducted on 3 cases. 14, 15 CDR scores the severity of symptoms of dementia using a composite range of 0 to 3, where 0 indicates no symptoms of dementia and 3 marks severe impairment. Pathology data on cases is presented in Table 2 . Neuritic and diffuse plaques were scored semiquantitatively according to CERAD methods. 16 CERAD (0-3 or none, sparse, moderate, frequent) and Braak (0-6) scores are measures of the severity of neuritic plaque and NFT accumulation, respectively. The Amyloid Braak CERAD score was used as a global measure of AD pathology.
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Tissue Processing and Golgi-Cox Staining (2) not obscured by large staining debris, and (3) fully impregnated. If the cell met the criteria, a single dendritic length was imaged. Dendrite selection criteria were: (1) unobstructed/isolated/not overlapping other dendrites, (2) length > 30 mm, and (3) diameter approximately 1 mm. If > 2 dendrites fulfilled the criteria from a single cell, the first dendrite clockwise was the only dendrite selected. If no dendrites from a cell fulfilled the criteria, another cell was viewed and scrutinized. All imaging was conducted by a single, blinded experimenter. Each tissue slice was initially viewed under low 34 magnification to establish the region of interest (layers II and III). Next, a pyramidal cell dendrite within the region of interest was viewed at 360 magnification to determine whether the dendrite fulfilled the above criteria. A maximum of 2 pyramidal cells were imaged per tissue slice. Z-stacks were captured with a z-step size of 0.1 mm. Each image was recorded using the following parameters: lamp, 100%; field stop, 1.5mm; exposure, 60 milliseconds; analog gain, 2.0-2.43; image size, 1,028 3 1,028 pixels (0.1619 3 0.1619 3 0.1 mm). Images were captured on a Nikon (Tokyo, Japan) Eclipse Ni upright microscope with 
Three-Dimensional Digital Image Reconstruction
Dendrite and spine reconstructions were conducted by a single, blinded experimenter. Image stacks of neuronal dendrites were imported to Neurolucida 360 (2.70.1, MBF Biosciences, Williston, VT). Dendrites were traced using a semiautomated directional kernel algorithm. Spines were traced using voxel clustering. Initiation and termination points for dendrite reconstruction were established using the following criteria: must be 10 lm away from the distal tip of the dendrite, must contain consistent dendrite diameter, must have a level axis with limited movement in the z plane, and must be 30 lm in length. Next, the experimenter manually scrutinized each assigned point in the x, y, and z plane to verify that the point was located on the dendrite or spine and not artificially assigned. Points were scrutinized first by viewing the dendrite at individual x-z or y-z planes and by ensuring that points were correctly positioned at the midline of the dendrite. Afterward, points were verified in the x-y plane, and the diameter of each point was confirmed to match the dendrite diameter. Dendritic spine reconstruction utilized the following parameters for classification: outer range, 7.0 lm; minimum height, 0.3 lm; detector sensitivity, 90 to 125%; minimum count, 8 voxels. Dendritic spines were traced as the experimenter traversed the full dendrite z-plane and inspected the x-y plane at each individual z-step. The morphology of each reconstructed spine was carefully scrutinized by verifying that axial smear did not cause misrepresentation, and the merge and slice tools were used to correct inconsistencies. Spine backbone was used in recording spine extent and in spine classification. The positioning of each backbone point (including point of greatest breadth) was confirmed by the experimenter. To correct a misrepresentative backbone, the spine was viewed from the z-plane, and experimenter moved backbone points in the x-y plane. Any repositioning in the x-z or y-z plane was performed while the spine was being viewed from the lateral angle. Morphometric analysis was conducted for each spine, and measurements categorized spines into thin, stubby, mushroom, and filopodia classes. Reconstructions were exported to Neurolucida Explorer (2.70.1, MBF Biosciences), where data were collected for quantitative analysis. The dendritic spine measurement parameters included spine extent and spine head diameter, among others. These parameters were exported and collected in Microsoft (Redmond, WA) Excel. Derived measurements, such as spine density per dendrite surface area, were calculated from raw measurement data. For spine classification, the following established parameters were used: head-to-neck ratio, 1.1; length-to-head ratio, 2.5; mushroom head size, 0.35 mm; filopodium length, 3.0 lm. Spines with a head-to-neck ratio > 1.1 and head diameter > 0.35 lm were classified as mushroom. Spines were classified as filopodia, or thin, if head-to-neck ratio was < 1.1, and either (1) length-to-head ratio was > 2.5 or (2) head size was < 0.35 lm. Of these, if the total length was >3.0 lm, the spine was classified as filopodia, and if <3.0 lm as thin. Spine density was calculated by determining the number of spines per micrometer of dendrite length or the number of spines per square micrometer of dendrite surface area. Spine extent was defined as the curvilinear backbone length from the insertion point to the most distal point of the spine head. Head diameter was defined as the breadth of the spine head at its widest cross-sectional point. Both morphological measurements and corresponding backbone reconstructions were verified. Notably, our spine structure and density measurements are consistent with similar studies assessing dendritic spine density and morphology in human samples. Prior investigations using electron microscopy in aged neocortex exhibit strong similarities to our reported spine length and head diameter. [18] [19] [20] Additional studies measuring spine structure characteristics in human and nonhuman primates using confocal and light microscopy report spine measurements that are highly consistent with our findings. [21] [22] [23] [24] In total, 5,569 mm of dendrite length and 4,297 spines were analyzed in this study. Approximately 118 spines per control case, 109 spines per CAD case, and 95 spines per AD case were analyzed.
Statistical Analysis
Statistical analyses were conducted with Prism 6.0 (GraphPad Software, La Jolla, CA). Data are presented as mean 6 standard error of the mean (SEM), and all graph error bars represent SEM. All statistical tests were 2-tailed, with the threshold for statistical significance set at 0.05. To compare aggregate spine densities among conditions, the mean spine density per patient was calculated. These patient means were then averaged per condition and reported as a condition mean. Mean spine densities for each spine class were similarly accumulated. Statistical comparisons included unpaired t test, 1-way analysis of variance (ANOVA) with Tukey comparisons test, 2-way ANOVA with Tukey or Bonferroni multiple comparison test, linear regression analysis, and 2-sample Kolmogorov-Smirnov test. Possible covariants were assessed for spine densities and morphology. Sex, age, and postmortem interval were compared against the patient means for each parameter using 2-way ANOVA, linear regression, or t tests. For spine morphology, cumulative distributions of dendritic spine extent or head diameter are reported for each condition. The D'Agostino and Pearson omnibus normality test determined that these spine morphology parameters were not normally distributed, so nonparametric Kolmogorov-Smirnov tests were used. Two-sample Kolmogorov-Smirnov tests compared the frequency of spine morphology among spine populations between each pair of conditions. 25, 26 Additionally, 1-way ANOVA with Tukey post hoc test was performed to compare morphology among conditions.
Results
Using the Golgi-Cox technique, we compared the density of dendritic spines within layers II and III pyramidal neuron dendrites of BA46 dorsolateral prefrontal cortex (DLPFC) in controls, CAD, and AD cases (see Tables 1  and 2 ). BA46 was selected because it is a region tightly linked to cognitive performance, including working memory, and is highly vulnerable in AD. 27, 28 We developed and optimized a method to trace impregnated dendrites from bright-field microscopic images that enabled accurate 3-dimensional digital reconstruction of dendritic structure (Fig 1) . Spine density, measured per dendrite length or dendrite surface area, was similar among control and CAD cases but reduced in AD (Fig 2, Supplementary Tables 1  and 2 ). The mean ages of the control, CAD, and AD groups were not significantly different. Linear regression analysis indicated that spine density was independent of sex or postmortem interval and that spine density changes within disease states were not associated with age (Supplementary Tables 2 and 3) . However, collective analysis of all cases revealed that age was inversely proportional to spine density (F 1,39 5 6.570, R 2 5 0.1442, p 5 0.0143), which supports past findings in aging mammals. 29, 30 The amyloid hypothesis of AD posits that increased soluble and insoluble Ab levels induce a cascade of processes that manifest in NFT formation and synaptic loss, resulting in clinical dementia. 31 Linear regression analysis of all cases indicated that, irrespective of disease state, spine density was not associated with Ab plaque severity (neuritic or diffuse plaque scores) but did display negative correlation with the degree of NFT distribution (F 1,39 5 6.495, R 2 5 0.1428, p 5 0.0149) and Braak staging (F 1 Fig 3A- D, Supplementary Table 3) . Notably, among AD cases there was no correlation with spine density and Braak staging (see Fig 3E, Supplementary Table 3 ).
Despite high levels of Ab plaques and NFTs in CAD brains, the mean spine density measurements were not significantly different from controls (see Fig 2A- D,  Supplementary Tables 1 and 2 ). This may contribute to the lack of cognitive impairment in CAD cases; however, we hypothesized that maintenance of cognitive function in an environment of AD pathology would involve structural remodeling of dendritic spines. To test this, we assessed spine morphology across control, CAD, and AD cases. Dendritic spine morphology influences excitatory neurotransmission and synaptic plasticity, and spines can be classified on the basis of their 3-dimensional structure as stubby, mushroom, or thin. 13, 32, 33 Stubby spines are theorized to be transitional, mushroom spines represent more stable structures, and thin spines are more dynamic. Dendritic filopodia are actin-rich protrusions that are widely considered the precursors of spines. 34 Thin spines were reduced significantly in AD compared to CAD cases (2-way ANOVA: p 5 0.0003; Tukey: p 5 0.0004), whereas stubby spine density was decreased significantly in CAD and AD compared to controls (Tukey: CAD, p 5 0.031; AD, p 5 0.0054). Numbers of mushroom spines were reduced significantly in AD compared to CAD (Tukey: p 5 0.0405), but filopodia did not differ significantly among disease states (Fig 4A,   Supplementary Tables 1 and 2 ). Linear regression analysis across all cases revealed that age and sex did not correlate with spine classification densities (see Fig 4B, C, Supplementary Table 3 ). To further analyze spine structure, spine extent (length) was measured among control, CAD, and AD dendrites. Mean spine extent was increased significantly in CAD cases compared to controls or AD (ANOVA: F 2,4548 5 36.17, p < 0.0001; Tukey: controls, p < 0.0001; AD, p < 0.0001; Fig 5, Supplementary Tables 1 and 2 ). To examine this change in length in more detail, the cumulative distribution of spine extents for each disease state was plotted. The cumulative frequency plots indicated that CAD cases segregate from controls and AD based on spine extent (Kolmogorov-Smirnov: controls, D 5 0.1221, p < 0.0001; AD, D 5 0.1455, p < 0.0001). Notably, age and sex did not influence overall mean Tables 1 and 2 ). Thin spine extent was reduced in AD cases compared to CAD, and mushroom spine extent was increased in CAD cases compared to controls and AD. However, these results were not significant.
Next, spine head diameter was measured among control, CAD, and AD dendrites. Mean spine head diameter was reduced significantly in AD cases compared to controls (ANOVA: Notably, controls segregate from CAD at <0.4 mm head diameter, likely due to reduced thin spine head diameter in CAD cases. Notably, age and sex did not influence overall mean spine head diameter (see Supplementary  Tables 2 and 3 ). Analysis of spine classes revealed that thin spine head diameter was reduced selectively in CAD cases compared to controls and AD (ANOVA: 
Discussion
In this study, we used optimized 3-dimensional modeling of dendritic spines to reveal that maintenance of thin and mushroom spine populations combined with cumulative increased spine extent distinguished CAD cases from AD. These observations provide cellular evidence to support the hypothesis that spine plasticity is a mechanism of cognitive resilience that protects older individuals with AD pathophysiology from developing dementia. 35 Concomitant alternations in extent and head diameter among spine classes in CAD cases may reflect more rapid plasticity to maintain information storage. 36 For instance, cumulative increases in spine extent through the DLPFC could sustain working memory in an environment of Ab plaques and NFTs by extending their reach to maintain degenerating connections or facilitating new synaptic inputs. Moreover, preservation of thin and mushroom spine density in CAD appears to be important for cognitive maintenance, whereas stubby spines may be less essential. These results support findings in rhesus monkeys, where selective loss of thin spines in BA46 is associated with age-related memory impairment. 30 Maintenance of thin spines suggests preservation of dynamic synapses that are formed or remodeled during learning and memory in adulthood. 37, 38 Recently, positron emission tomography (PET) imaging of tau indicated that NFT distribution across cognitively normal older individuals and AD patients strongly correlated to Braak staging in postmortem tissue. 39 Using the findings here, a comparison of PET tau imaging and its correlative Braak stage could be used to extrapolate a hypothetical representation of synaptic density and structure in the DLPFC. However, no correlation with spine density and Braak staging was observed among AD cases, suggesting that a clinical diagnosis of AD is associated with reduced spine density irrespective of Braak stage (see Fig 3E, Supplementary Table 3) . However, the limited numbers of AD cases that display Braak stage I-III at autopsy hinder this analysis. 11 C-Pittsburgh compound B imaging studies suggest that only 13% of cognitively normal individuals who are positive for Ab will transition to mild cognitive impairment or AD. 40 Based on this, comparison of structural plasticity among controls, and CAD and AD cases may be interpreted in 2 ways. If the CAD individuals lived to develop dementia, then the observed phenotypes could reflect necessary synaptic structure changes during the transition from preclinical to symptomatic AD. Alternatively, if the CAD individuals lived and remained immune to dementia, then the observed phenotypes could represent an inherent protective mechanism that prevents the onset of dementia (Fig 7) . In either scenario, these findings emphasize spine plasticity as a mechanism of cognitive resilience and highlight structural plasticity as a substrate for therapeutic intervention during the preclinical phase of AD.
